Amicus Therapeutics | Advancing Therapies to Treat Rare Diseases

A R

re Story

We Believe In Our Future.

A R

re Commitment

Michael, 25 Living with Fabry Disease

We are a biotechnology company at the forefront of advanced therapies to treat a range of devastating rare diseases.

Executive Chairman, John F. Crowley Delivers Notre Dame Commencement Address.

We are leveraging our innovative technology platforms to develop treatments for human genetic diseases.

Be inspired by people living with rare disease across the globe.

Join a team committed to changing the lives of patients with rare metabolic diseases. Now hiring in multiple locations.